Literature DB >> 20693420

N-ethyl-N-nitrosourea-induced mutation in ubiquitin-specific peptidase 18 causes hyperactivation of IFN-αß signaling and suppresses STAT4-induced IFN-γ production, resulting in increased susceptibility to Salmonella typhimurium.

Etienne Richer1, Caitlin Prendergast, Dong-Er Zhang, Salman T Qureshi, Silvia M Vidal, Danielle Malo.   

Abstract

To deepen our knowledge of the natural host response to pathogens, our team undertook an in vivo screen of mutagenized 129S1 mice with Salmonella Typhimurium. One mutation affecting Salmonella susceptibility was mapped to a region of 1.3 Mb on chromosome 6 that contains 15 protein-coding genes. A missense mutation was identified in the Usp18 (ubiquitin-specific peptidase 18) gene. This mutation results in an increased inflammatory response (IL-6, type 1 IFN) to Salmonella and LPS challenge while paradoxically reducing IFN-gamma production during bacterial infection. Increased STAT1 phosphorylation correlated with impaired STAT4 phosphorylation, resulting in overwhelming IL-6 secretion but reduced IFN-gamma production during infection. The reduced IFN-gamma levels, along with the increased inflammation, rationalize the S. Typhimurium susceptibility in terms of increased bacterial load in target organs and cytokine-induced septic shock and death.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20693420      PMCID: PMC3987673          DOI: 10.4049/jimmunol.1000890

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  46 in total

1.  Icsbp1/IRF-8 is required for innate and adaptive immune responses against intracellular pathogens.

Authors:  Karine Turcotte; Susan Gauthier; Danielle Malo; Mifong Tam; Mary M Stevenson; Philippe Gros
Journal:  J Immunol       Date:  2007-08-15       Impact factor: 5.422

Review 2.  Forward genetic dissection of immunity to infection in the mouse.

Authors:  S M Vidal; D Malo; J-F Marquis; P Gros
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

Review 3.  Chemical mutagenesis: a new strategy against the global threat of infectious diseases.

Authors:  Etienne Richer; Salman T Qureshi; Silvia M Vidal; Danielle Malo
Journal:  Mamm Genome       Date:  2008-06-17       Impact factor: 2.957

Review 4.  TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity.

Authors:  Roberto Baccala; Kasper Hoebe; Dwight H Kono; Bruce Beutler; Argyrios N Theofilopoulos
Journal:  Nat Med       Date:  2007-05       Impact factor: 53.440

5.  ATP-sensitive potassium channels mediate survival during infection in mammals and insects.

Authors:  Ben Croker; Karine Crozat; Michael Berger; Yu Xia; Sosathya Sovath; Lana Schaffer; Ioannis Eleftherianos; Jean-Luc Imler; Bruce Beutler
Journal:  Nat Genet       Date:  2007-11-18       Impact factor: 38.330

6.  The level of hepatitis B virus replication is not affected by protein ISG15 modification but is reduced by inhibition of UBP43 (USP18) expression.

Authors:  Jung-Hwan Kim; Jiann-Kae Luo; Dong-Er Zhang
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

Review 7.  Novel primary immunodeficiencies revealed by the investigation of paediatric infectious diseases.

Authors:  Jacinta Bustamante; Stéphanie Boisson-Dupuis; Emmanuelle Jouanguy; Capucine Picard; Anne Puel; Laurent Abel; Jean-Laurent Casanova
Journal:  Curr Opin Immunol       Date:  2008-02       Impact factor: 7.486

8.  Jinx, an MCMV susceptibility phenotype caused by disruption of Unc13d: a mouse model of type 3 familial hemophagocytic lymphohistiocytosis.

Authors:  Karine Crozat; Kasper Hoebe; Sophie Ugolini; Nancy A Hong; Edith Janssen; Sophie Rutschmann; Suzanne Mudd; Sosathya Sovath; Eric Vivier; Bruce Beutler
Journal:  J Exp Med       Date:  2007-04-09       Impact factor: 14.307

9.  Pyruvate kinase deficiency confers susceptibility to Salmonella typhimurium infection in mice.

Authors:  Marie-France Roy; Noémie Riendeau; Christian Bédard; Pierre Hélie; Gundula Min-Oo; Karine Turcotte; Philippe Gros; François Canonne-Hergaux; Danielle Malo
Journal:  J Exp Med       Date:  2007-11-06       Impact factor: 14.307

10.  High basal STAT4 balanced by STAT1 induction to control type 1 interferon effects in natural killer cells.

Authors:  Takuya Miyagi; M Pilar Gil; Xin Wang; Jennifer Louten; Wen-Ming Chu; Christine A Biron
Journal:  J Exp Med       Date:  2007-09-10       Impact factor: 14.307

View more
  26 in total

1.  Selective inactivation of USP18 isopeptidase activity in vivo enhances ISG15 conjugation and viral resistance.

Authors:  Lars Ketscher; Ronny Hannß; David J Morales; Anja Basters; Susana Guerra; Tobias Goldmann; Annika Hausmann; Marco Prinz; Ronald Naumann; Andrew Pekosz; Olaf Utermöhlen; Deborah J Lenschow; Klaus-Peter Knobeloch
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-20       Impact factor: 11.205

2.  The probacterial effect of type I interferon signaling requires its own negative regulator USP18.

Authors:  Namir Shaabani; Nadine Honke; Nhan Nguyen; Zhe Huang; Kei-Ichiro Arimoto; Daniel Lazar; Taylor K Loe; Karl S Lang; Marco Prinz; Klaus-Peter Knobeloch; Dong-Er Zhang; John R Teijaro
Journal:  Sci Immunol       Date:  2018-09-28

3.  USP18 lack in microglia causes destructive interferonopathy of the mouse brain.

Authors:  Tobias Goldmann; Nicolas Zeller; Jenni Raasch; Katrin Kierdorf; Kathrin Frenzel; Lars Ketscher; Anja Basters; Ori Staszewski; Stefanie M Brendecke; Alena Spiess; Tuan Leng Tay; Clemens Kreutz; Jens Timmer; Grazia M S Mancini; Thomas Blank; Günter Fritz; Knut Biber; Roland Lang; Danielle Malo; Doron Merkler; Mathias Heikenwälder; Klaus-Peter Knobeloch; Marco Prinz
Journal:  EMBO J       Date:  2015-04-20       Impact factor: 11.598

4.  Deubiquitinase USP18 Loss Mislocalizes and Destabilizes KRAS in Lung Cancer.

Authors:  Lisa Maria Mustachio; Yun Lu; Laura J Tafe; Vincent Memoli; Jaime Rodriguez-Canales; Barbara Mino; Pamela Andrea Villalobos; Ignacio Wistuba; Hiroyuki Katayama; Samir M Hanash; Jason Roszik; Masanori Kawakami; Kwang-Jin Cho; John F Hancock; Fadzai Chinyengetere; Shanhu Hu; Xi Liu; Sarah J Freemantle; Ethan Dmitrovsky
Journal:  Mol Cancer Res       Date:  2017-02-27       Impact factor: 5.852

Review 5.  Enterobacteria and host resistance to infection.

Authors:  Eugene Kang; Alanna Crouse; Lucie Chevallier; Stéphanie M Pontier; Ashwag Alzahrani; Navoun Silué; François-Xavier Campbell-Valois; Xavier Montagutelli; Samantha Gruenheid; Danielle Malo
Journal:  Mamm Genome       Date:  2018-05-21       Impact factor: 2.957

6.  Differential Immune Phenotypes in Human Monocytes Induced by Non-Host-Adapted Salmonella enterica Serovar Choleraesuis and Host-Adapted S. Typhimurium.

Authors:  Hiba Ibrahim; Basim Askar; Scott Hulme; Peter Neilson; Paul Barrow; Neil Foster
Journal:  Infect Immun       Date:  2018-09-21       Impact factor: 3.441

7.  Dual regulation of Stat1 and Stat3 by the tumor suppressor protein PML contributes to interferon α-mediated inhibition of angiogenesis.

Authors:  Kuo-Sheng Hsu; Xuan Zhao; Xiwen Cheng; Dongyin Guan; Ganapati H Mahabeleshwar; Yu Liu; Ernest Borden; Mukesh K Jain; Hung-Ying Kao
Journal:  J Biol Chem       Date:  2017-04-21       Impact factor: 5.157

8.  Functional validation of the genetic architecture of Salmonella Enteritidis persistence in 129S6 mice.

Authors:  Marie Chevenon; Mayss Naccache; Megan M Eva; Rabia T Khan; Danielle Malo
Journal:  Mamm Genome       Date:  2013-04-16       Impact factor: 2.957

9.  Survival analysis and microarray profiling identify Cd40 as a candidate for the Salmonella susceptibility locus, Ity5.

Authors:  S C Beatty; K E Yuki; M M Eva; S Dauphinee; L Larivière; S M Vidal; D Malo
Journal:  Genes Immun       Date:  2015-11-12       Impact factor: 2.676

10.  Suppression of hepcidin expression and iron overload mediate Salmonella susceptibility in ankyrin 1 ENU-induced mutant.

Authors:  Kyoko E Yuki; Megan M Eva; Etienne Richer; Dudley Chung; Marilène Paquet; Mathieu Cellier; François Canonne-Hergaux; Sophie Vaulont; Silvia M Vidal; Danielle Malo
Journal:  PLoS One       Date:  2013-02-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.